Indel B S.p.A. (BIT:INDB) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock?

Last week saw the newest half-year earnings release from Indel B S.p.A. (BIT:INDB), an important milestone in the company's journey to build a stronger business. It was a workmanlike result, with revenues of €108m coming in 3.8% ahead of expectations, and statutory earnings per share of €1.96, in line with analyst appraisals. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

After the latest results, the two analysts covering Indel B are now predicting revenues of €203.0m in 2025. If met, this would reflect a satisfactory 2.9% improvement in revenue compared to the last 12 months. Before this earnings report, the analysts had been forecasting revenues of €207.4m and earnings per share (EPS) of €1.80 in 2025. So we can see that while the consensus made a small dip in revenue estimates, it no longer provides an earnings per share estimate. This suggests that the market is now more focused on revenue after the latest result.

View our latest analysis for Indel B

There's been no real change to the consensus price target of €27.33, with Indel B seemingly executing in line with expectations.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that Indel B's revenue growth is expected to slow, with the forecast 5.9% annualised growth rate until the end of 2025 being well below the historical 8.6% p.a. growth over the last five years. Compare this to the 12 other companies in this industry with analyst coverage, which are forecast to grow their revenue at 5.8% per year. Factoring in the forecast slowdown in growth, it looks like Indel B is forecast to grow at about the same rate as the wider industry.

The Bottom Line

The clear low-light was that the analysts cut their forecast revenue estimates for Indel B next year. Sadly, they also downgraded their revenue forecasts, but the business is still expected to grow at roughly the same rate as the industry itself. The consensus price target held steady at €27.33, with the latest estimates not enough to have an impact on their price targets.

We have estimates for Indel B from its two analysts out to 2027, and you can see them free on our platform here.

We don't want to rain on the parade too much, but we did also find 2 warning signs for Indel B (1 doesn't sit too well with us!) that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.